Agenovir Corporation

Agenovir Corporation

Agenovir is developing a novel class of nuclease-based anti-viral therapeutics for diseases associated with viral reservoirs

Area of focus: 
Infectious Diseases & Vaccines
Graduation date: 
06/12/2017
Commencement date: 
09/21/2015

Share